Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methoxyflurane vs Ketorolac for Acute Traumatic Pain in ED
NCT04618497Phase 3Completed
- Sponsor
- Hospital Authority
- Start
- Oct 2020
- Primary completion
- Nov 2020
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of methoxyflurane in Acute traumatic pain (2 arms), sponsored by Hospital Authority. Primary endpoint: Change in pain intensity over 60 mins at 60 months. Started Oct 2020; status: completed.
02
Drugs
methoxyflurane
03
Conditions
Acute traumatic pain
Beyond the preview
Go deeper on NCT04618497.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04618497.